Xiangxue Pharmaceutical

Xiangxue Pharmaceutical became a "company limited by shares" on 29 December 1997 (roughly equivalent to public limited company); its shares were traded in ChiNext board of Shenzhen Stock Exchange since 2010.{{cite news|url=http://finance.ifeng.com/ipo/xgyw/20101126/2962124.shtml|script-title=zh:香雪制药上市前遭资本围猎 大股东蛇吞象涉嫌违法|date=26 November 2010|access-date=2 November 2017|last={{lang|zh|赵}}|first={{lang|zh|琳}}|newspaper={{lang|zh|华夏时报}}|via=ifeng.com|language=zh-cn}}

{{expand section|date=November 2017}}

• "Asia" brand soft drinks (licensed from an investment vehicle of the Guangzhou government)
• "Eisiti" Herbal Tea ({{zh|s=上清饮凉茶|p=Shàng qīng yǐn liáng chá}}, discontinued? )
• Jochi brand health supplement

{{expand list|date=November 2017}}

According to 2016 Annual Report,{{cite web|url=http://disclosure.szse.cn/m/finalpage/2017-03-25/1203197199.PDF|script-title=zh:2016年年度报告|trans-title=2016 Annual Report|date=25 March 2017|access-date=2 November 2017|publisher=Xiangxue Pharmaceutical|language=zh-cn|via=Shenzhen Stock Exchange}}{{Dead link|date=December 2024 |bot=InternetArchiveBot |fix-attempted=yes }}{{rp|28}} manufacturing and trading medicine accounted for 29.60% and 26.45% of its revenue, with an additional 32.94% from Chinese medicine; soft drinks accounted for 4.91%, it was followed by medical equipment and other revenue.

Eisiti was a competitor of Wong Lo Kat which was produced by Guangzhou Pharmaceuticals and Jiaduobao. The production of Eisiti was suspended in 2011, according to news report, despite the company denial.{{cite news|url=http://finance.jrj.com.cn/industry/2011/11/18181811595082.shtml|script-title=zh:香雪否认上清饮停产 小品牌凉茶挣扎求生|work={{lang|zh|羊城晚报}}|date=18 November 2011|access-date=1 November 2017|language=zh-cn|via=jrj.com.cn}}

The Chinese drugmaker Xiangxue Pharmaceutical Co. Ltd is developing a cutting-edge cancer therapy with American biotech firm Athenex Inc wherein the key technology that the two sides are working on are T-cell receptor-engineered T cells (TCR-T), a cancer immunotherapy.{{Cite web |title=Quick Take: China's Xiangxue Partners With U.S. Firm for Cancer Therapy - Caixin Global |url=https://www.caixinglobal.com/2018-07-04/quick-take-chinas-xiangxue-partners-with-us-firm-for-cancer-therapy-101292588.html |access-date=2023-07-08 |website=www.caixinglobal.com |language=en}}

{{updated|31 December 2016}}

{{col-begin}}

{{col-2}}

• {{zh|s=化州中药厂|l=Huazhou Chinese Medicine Factory }}
• {{zh|s=广州白云医用胶}}
• Xiangxue Asian Beverage ({{zh|s=香雪亚洲饮料}}, 63%)
• Jochi ({{zh|s=九极生物}})
• {{zh|s=湖北天济中药饮片}} (55%)

{{col-2}}

• {{zh|s=亳州市沪谯药业}}
• {{zh|s=山西新亿群药业}}
• Chongqing Xiangxue Yiyao ({{zh|s=重庆香雪医药}})
• Guangdong Xiangxue ({{zh|s=广东香雪药业}})

{{col-end}}

{{updated|31 December 2016}}

• Charmacy Pharmaceutical ({{SEHK|02289}})

{{see also|Xiangxue Pharmaceutical (football)}}

Xiangxue Pharmaceutical was a sponsor of Guangzhou F.C. from 2002 to 2003 season. As of 2017, it was owned by Evergrande Group, a property developer and Alibaba Group, parent company of taobao.com, and the club was known as Guangzhou Evergrande Taobao F.C..

Xiangxue Pharmaceutical also sponsored {{ill|Guangdong Mingfeng|zh|广东名峰足球俱乐部}}, another youth football team that based Zhaoqing, Guangdong Province to play in Hong Kong First Division League, the professional league of Hong Kong S.A.R., China (across the border of the Guangdong Province) as Xiangxue Pharmaceutical for 2001–02 season.{{cite news|url=http://sports.sina.com.cn/c/2001-08-17/17172377.shtml|script-title=zh:广东名峰香雪制药足球队参加新赛季香港联赛|date=17 August 2001|access-date=1 November 2017|work=Nanfang Daily|publication-place=Guangzhou|publisher=Nanfang Media Group|language=zh-cn|via=Sina}} It was replaced by the reserve team of Guangzhou F.C. in 2002–03 season{{cite news|url=http://sports.sina.com.cn/c/2002-09-19/1529318643.shtml|script-title=zh:香港足球联赛首次进入内地 区楚良谢育新将到场助兴|date=19 September 2002|access-date=2 November 2017|newspaper={{lang|zh|羊城晚报}}|publication-place=Guangzhou|language=zh-cn|via=Sina}} and 2003–04 season. In 2004–05 season, Xiangxue Pharmaceutical was the sponsor name of two different teams, that not related to Guangzhou F.C. and Zhaoqing-based club.

Xiangxue Pharmaceutical also sponsored Hong Kong football club Sun Hei SC from 2005–06 to 2006–07 season, as well as Chinese football club Shenzhen F.C. in 2007{{cite news|url=http://sports.sina.com.cn/j/2007-01-08/17362680572.shtml|script-title=zh:深足正式更名上清饮队 约定部分场次移师广州待回应|date=8 January 2007|access-date=2 November 2017|work=Sina Sports|language=zh-cn}} and 2008 season. Which the club was known as Shenzhen Xiangxue Eisiti (Shenzhen Xiangxue Shangqingyin) at that time; Guangzhou F.C. was owned by Xiangxue Pharmaceutical's competitor Guangzhou Pharmaceuticals from 2005 to 2009.

Shenzhen F.C. II, the B team of Shenzhen F.C., was also played in Hong Kong as Xiangxue Eisiti in 2008–09 season.

Xiangxue Pharmaceutical also secured the naming rights of 2003–04 Hong Kong First Division League{{cite news|url=http://sports.sohu.com/16/86/news212678616.shtml|script-title=zh:广州香雪制药公司冠名香港足球甲组联赛|date=31 August 2003|access-date=2 November 2017|author={{lang|zh|小唐}}|newspaper=Southern Metropolis Daily|publication-place=Guangzhou|publisher=Nanfang Media Group|language=zh-cn|via=sohu.com}} and 2008–09 Hong Kong Senior Challenge Shield.{{cite web|url=http://news.sina.com/j/2008-11-21/02544082660.shtml|script-title=zh:上清飲冠名香港銀牌杯 林誠駒評港隊衝超及武漢退出|date=20 November 2008|access-date=2 November 2017|publisher=Sina|publication-place=Beijing|language=zh-hant}}

{{as of |2016|12|31}},{{rp|78–81}} two investment vehicles of Chen Shumei ({{zh|s=陈淑梅|p=Chén Shū Méi|j=can4 suk6 mui4 }}) and Wang Yonghui ({{zh|s=王永辉|p=Wáng Yǒng Huī|j=wong4 wing5 fai1}}), owned 36.98% shares of the company as the largest shareholder. According to the company, they were a couple,{{cite web|url=http://disclosure.szse.cn/finalpage/2010-12-14/58779188.PDF|script-title=zh:首次公开发行股票并在创业板上市公告书|date=14 December 2010|access-date=2 November 2017|publisher=Xiangxue Pharmaceutical|language=zh-cn|via=Shenzhen Stock Exchange}} and Ms. Chen owned most of the stake in their investment vehicles. Part of the shares they owned were pledged ({{zh|s=质押}}).{{rp|78}} Ms. Chen ceased as the director of the company on 25 May 2016.{{rp|85}}

It was followed by two investment accounts of the National Social Security Fund for a total of 4.09%, a civilian-owned water supply company from Luogang, Guangzhou for 4.06%, Central Huijin Investment for 1.51% and some private equity funds that were managed by the banks.{{rp|79}}

{{reflist|group=nb}}

{{reflist}}

• {{official website}} {{in lang|zh-hans}} {{in lang|en}}

{{Pharmaceutical companies of China}}

Category:Pharmaceutical companies of China

Category:Drink companies of China

Category:Companies listed on the Shenzhen Stock Exchange

Category:manufacturing companies based in Guangzhou

Category:Civilian-run enterprises of China

Category:Chinese companies established in 1986

Category:Pharmaceutical companies established in 1986